← Evidence map

RetractedArticleFrontiers in oncology2023

A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinoma.

Qing Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2023
2024
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37064142